Showing 3131-3140 of 3223 results for "".
- Novartis to Cut Over 2000 Jobs in Switzerland, UKhttps://modernod.com/news/novartis-to-cut-over-2000-jobs-in-switzerland-uk/2479850/Novartis announced that it will slash more than 2,000 jobs by 2022, including eliminating 1,700 positions in Switzerland and around 400 roles in the UK, as it looks to increase profitability. The move comes as the company consolidates manufacturing and shifts positions elsewhere as part of plans
- Zeiss Introduces Integrated Diagnostic Imaging (IDI) Platform at ESCRShttps://modernod.com/news/zeiss-presents-integrated-data-driven-digital-solutions-at-escrs/2479859/Zeiss presented its newest digital diagnostic solutions for retinal diseases and glaucoma, along with new astigmatism management options in cataract surgery, this week at the ESCRS & EURETINA exhibition. “Digitalization o
- Nidek Launches the GS-1 Gonioscopehttps://modernod.com/news/nidek-launches-the-gs-1-gonioscope/2479862/Nidek has announced the launch of the GS-1 Gonioscope. The GS-1 is the first automated gonioscopy device enabling 360-degree color iridocorneal angle imaging allowing more clinicians to reliably perform gonioscopy in
- Oculus to Present New Formulas for the Pentacam AXLhttps://modernod.com/news/oculus-to-present-new-formulas-for-the-pentacam-axl-advanced-barrett-and-olsen-formulas/2479866/At the ESCRS 2018 in Vienna, Oculus is introducing the advanced Barrett Toric calculator, including the posterior cornea, and the Olsen ray-tracing formula, within the IOL calculator of the Pentacam AXL. Both formulas are available to all Pentacam AXL users in a free software update. The n
- Neurolens Appoints Thomas J. Chirillo as Chief Commercial Officerhttps://modernod.com/news/neurolens-appoints-thomas-j-chirillo-as-chief-commercial-officer/2479876/Neurolens announced the appointment of Thomas J. Chirillo as Chief Commercial Officer. An accomplished senior healthcare executive with deep experience in the eye care space, Mr. Chirillo brings almost 4 decades of sales and marketing experience to neurolens. “We’re thrilled to have someon
- Katena Products Announces Launch of the New Katena.comhttps://modernod.com/news/katena-products-announces-launch-of-the-new-katena-com/2479878/Katena Products has announced the launch of the new katena.com, an interactive and engaging ecommerce and education portal. The new site enables existing and prospective customers to review the complete assortment of Katena products and immediately order online. The new site integrates all
- Diopsys Highlights Educational Initiatives For ESCRS 2018https://modernod.com/news/diopsys-highlights-educational-initiatives-for-escrs-2018/2479883/Diopsys announced educational initiatives for the ESCRS 2018 Congress in Vienna, Austria, September 22-26. In addition to presentations that highlight how the various forms of testing available on Diopsys devices add to the management of eye care patients, the company will also be introducing the
- Market Scope: Ophthalmic Laser Market Expected to Total $400 Million in 2018https://modernod.com/news/market-scope-ophthalmic-laser-market-expected-to-total-400-million-in-2018/2479885/Global revenues for ophthalmic lasers—photocoagulation, photodisruption (YAG), and SLT—along with maintenance, accessories, and endoprobes, will total more than $400 million in 2018 and grow
- Sun Pharma Receives FDA Approval for Xelpros to Treat Open-Angle Glaucoma or Ocular Hypertensionhttps://modernod.com/news/sun-pharma-and-sparc-announced-fda-approval-of-xelpros-to-treat-open-angle-glaucoma-or-ocular-hypertension/2479886/Sun Pharmaceutical Industries announced FDA approval of Xelpros (latanoprost ophthalmic emulsion 0.005%) for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension. Xelpros is the first and only form of latanoprost that is not formulated with benzalkonium
- LumiThera to Debut Valeda Light Delivery System at EURETINAhttps://modernod.com/news/lumithera-to-debut-valeda-light-delivery-system-at-euretina/2479887/LumiThera announced that it will debut the Valeda Light Delivery System for the treatment of dry AMD in the exhibition hall at the EURETINA meeting in Vienna. It will also host a symposium on photobiomodulation (PBM) technology entitled, “Photobiomodulation: An Innovative, Mitochondria-targ